SCHEMBL7372256

SCHEMBL7372256

CCOC(=O)CN1CCNC(=O)C1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.46
GSK3A P49840 2/20 0.42
GSK3B P49841 2/20 0.42
THRB P10828 4/20 0.42
POLB P06746 3/20 0.42
ELANE P08246 1/20 0.41
TDP1 Q9NUW8 2/20 0.39
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.39
PIN1 Q13526 1/20 0.39
PIN4 Q9Y237 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4109529 0.98 TSHR (0.58) TSHRSMN1; SMN2GSK3AGSK3BTHRB
SCHEMBL4385456 0.85 TSHR (0.64) TSHRTHRBPOLB
SCHEMBL12552396 0.84 SMN1; SMN2 (0.51) TSHRSMN1; SMN2THRBPOLBTDP1
SCHEMBL4386122 0.82 TSHR (0.61) TSHRTHRB
SCHEMBL28507628 0.80 SMN1; SMN2 (0.45) TSHRSMN1; SMN2THRBPOLBTDP1
Ethyl Piperazinoacetate SCHEMBL5699 0.80 SIGMAR1 (0.49) TSHRGSK3AGSK3BPOLBELANE
SCHEMBL20821039 0.79 SMN1; SMN2 (0.49) TSHRSMN1; SMN2THRBPOLBKMT2A
SCHEMBL12226469 0.78 SMN1; SMN2 (0.51) TSHRSMN1; SMN2THRBPOLBKMT2A
Ethyl Piperazinoacetate SCHEMBL17271810 0.78 SIGMAR1 (0.47) TSHRSMN1; SMN2GSK3AGSK3BELANE
Ethyl Piperazinoacetate SCHEMBL16528281 0.78 SIGMAR1 (0.47) TSHRSMN1; SMN2GSK3AGSK3BELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114328-A ANTICOAGULANTS; BLOOD DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-09-05 US disclosed
EP-0970950-A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists DuPont Pharmaceuticals Company (US) 2000-01-12 EP disclosed
US-5849736-A Isoxazoline and isoxazole fibrinogen receptor antagonists THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-15 US disclosed
US-5559232-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1996-09-24 US disclosed
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP disclosed
WO-1995014683-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-01 WO disclosed